7 Patents
- US123446572025CD20 Therapies, CD22 Therapies, and Combination Therapies with a CD19 Chimeric Antigen Receptor (car)-expressing Cell
The Trustees Of The University Of Pennsylvania
0 cites - US122275882025Use of CD2/5/7 Knock-out Anti-cd2/5/7 Chimeric Antigen Receptor T Cells Against T Cell Lymphomas and Leukemias
The Trustees Of The University Of Pennsylvania
0 cites - US122140372025Treatment of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - USRE0498472024Nucleic Acid Molecules Encoding Chimeric Antigen Receptors Comprising a CD20 Binding Domain
The Trustees Of The University Of Pennsylvania
0 cites - US118722492024Method of Treating Cancer by Administering Immune Effector Cells Expressing a Chimeric Antigen Receptor Comprising a CD20 Binding Domain
The Trustees Of The University Of Pennsylvania
0 cites - US116739642023Use of CD2/5/7 Knock-out Anti-cd2/5/7 Chimeric Antigen Receptor T Cells Against T Cell Lymphomas and Leukemias
The Trustees Of The University Of Pennsylvania
0 cites - US115914042023Treatment of Cancer Using a CD123 Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites